Are all adaptogens created equal? A comparative review and trend analysis of clinical data

Introduction The use of adaptogenic ingredients in dietary supplements and herbal medicines is increasingly common. The pharmacological effects of generally acknowledged adaptogens at tissue and cellular levels through various mechanisms result in a range of clinically relevant effects, such as increasing resilience during the stress response, supporting more rapid recovery from stressors, and decreasing the intensity of post-stress exhaustion. While clinical effects for adaptogens should be non-specific, traditional use and commercial marketing suggest different applications for individual adaptogens. To this end, the authors conducted a comparative review of clinical research to test the hypothesis based on traditional understanding that adaptogen-specific effect profiles exist and that adaptogens have differentiable clinical relevance. Methods A comparative trend analysis of clinical evidence using accepted vote-counting methodology and data synthesis was conducted on seven generally acknowledged adaptogens: ashwagandha ( Withania somnifera ), schisandra ( Schisandra spp.), eleuthero ( Eleutherococcus senticosus ), rhodiola ( Rhodiola rosea ), Asian ginseng ( Panax ginseng ), reishi (species of Ganoderma ), and cordyceps (species of Cordyceps and Ophiocordyceps along with affiliated Paecilomyces hepiali ). Results A total of 275 clinical studies were included and scored based on primary and secondary outcomes across seven clinical outcome domains: energy, cognition, mood, sleep, immunologic and inflammatory balance, cardiometabolic health, and the reproductive system. Trend analysis of this dataset identified which adaptogens showed significant positive directions of effect in each domain, and demonstrated some significant differences in clinical outcome distribution profiles for each adaptogen. Discussion Individual adaptogens show unique effect profiles measured by the outcomes of clinical research in diverse domains, corroborated by traditional use.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-09
DOI
https://doi.org/10.3389/fphar.2026.1980715
Primary Topic
Medicinal Plants and Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Are all adaptogens created equal? A comparative review and trend analysis of clinical data

Thomas Brendler, Aaron Jenks, Marisa Williams, Guido Masé
Frontiers in Pharmacology
Medicinal Plants and Bioactive Compounds
article

Are all adaptogens created equal? A comparative review and trend analysis of clinical data

Thomas Brendler, Aaron Jenks, Marisa Williams, Guido Masé
article en

Abstract

Introduction The use of adaptogenic ingredients in dietary supplements and herbal medicines is increasingly common. The pharmacological effects of generally acknowledged adaptogens at tissue and cellular levels through various mechanisms result in a range of clinically relevant effects, such as increasing resilience during the stress response, supporting more rapid recovery from stressors, and decreasing the intensity of post-stress exhaustion. While clinical effects for adaptogens should be non-specific, traditional use and commercial marketing suggest different applications for individual adaptogens. To this end, the authors conducted a comparative review of clinical research to test the hypothesis based on traditional understanding that adaptogen-specific effect profiles exist and that adaptogens have differentiable clinical relevance. Methods A comparative trend analysis of clinical evidence using accepted vote-counting methodology and data synthesis was conducted on seven generally acknowledged adaptogens: ashwagandha ( Withania somnifera ), schisandra ( Schisandra spp.), eleuthero ( Eleutherococcus senticosus ), rhodiola ( Rhodiola rosea ), Asian ginseng ( Panax ginseng ), reishi (species of Ganoderma ), and cordyceps (species of Cordyceps and Ophiocordyceps along with affiliated Paecilomyces hepiali ). Results A total of 275 clinical studies were included and scored based on primary and secondary outcomes across seven clinical outcome domains: energy, cognition, mood, sleep, immunologic and inflammatory balance, cardiometabolic health, and the reproductive system. Trend analysis of this dataset identified which adaptogens showed significant positive directions of effect in each domain, and demonstrated some significant differences in clinical outcome distribution profiles for each adaptogen. Discussion Individual adaptogens show unique effect profiles measured by the outcomes of clinical research in diverse domains, corroborated by traditional use.

Frontiers in PharmacologyVol. 17
University of Illinois Urbana-Champaign (US), University of Johannesburg (ZA), University of Illinois Chicago (US), Southern Cross University (AU)
Medicinal Plants and Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon